This page includes the latest FDA filings for Aft Pharmaceuticals L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| NEW ZEALAND | NEW ZEALAND STOCK EXCHANGE | AFT | DUNS 591383294 |
| Registration Number | 3011756349 |
| FEI Number | 3011756349 |
| Name | Michael van der Woude |
| Owner & Operator | AFT Pharmaceuticals Limited |
| Contact Address | Level 1/129 Hurstmere Road Takapuna NZ-AUK Auckland 0622 NZ |
| Official Correspondent |
|
| US Agent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | 2500 Bee Cave Road Bldg 1, Suite 300 Austin, TX 78746 US |
| Establishment Type | Develop Specifications But Do Not Manufacture At This Facility |
Device Company | Device | Date |
|---|---|---|
| AFT Pharmaceuticals US, Inc. | Prescription Medication | 2024-10-30 |
| AFT Pharmaceuticals US, Inc. | Prescription Medication | 2024-03-01 |
Michael van der Woude [AFT Pharmaceuticals Limited] | NasoSurf | 2016-11-29 |
| NCAGE Code | ETK30 | AFT PHARMACEUTICALS LTD |
| CAGE Code | ETK30 | AFT PHARMACEUTICALS LTD |